TY - JOUR T1 - Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - e46 LP - e46 DO - 10.1136/annrheumdis-2013-204016corr1 VL - 75 IS - 7 A2 - , Y1 - 2016/07/01 UR - http://ard.bmj.com/content/75/7/e46.abstract N2 - Tanaka Y, Hirata S, Kubo S, et al. Discontinuation of adalimumab after … ER -